MariMed Statistics
Total Valuation
MariMed has a market cap or net worth of 61.91 million. The enterprise value is 156.55 million.
| Market Cap | 61.91M |
| Enterprise Value | 156.55M |
Important Dates
The next estimated earnings date is Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MariMed has 381.00 million shares outstanding. The number of shares has increased by 2.54% in one year.
| Shares Outstanding | 381.00M |
| Shares Change (YoY) | +2.54% |
| Shares Change (QoQ) | +1.15% |
| Owned by Insiders (%) | 10.11% |
| Owned by Institutions (%) | 0.30% |
| Float | 342.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.39 |
| PB Ratio | 0.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.32, with an EV/FCF ratio of -72.78.
| EV / Earnings | -9.01 |
| EV / Sales | 1.00 |
| EV / EBITDA | 7.32 |
| EV / EBIT | 17.03 |
| EV / FCF | -72.78 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 1.00.
| Current Ratio | 1.30 |
| Quick Ratio | 0.46 |
| Debt / Equity | 1.00 |
| Debt / EBITDA | 4.10 |
| Debt / FCF | -40.70 |
| Interest Coverage | 1.24 |
Financial Efficiency
Return on equity (ROE) is -18.21% and return on invested capital (ROIC) is 3.35%.
| Return on Equity (ROE) | -18.21% |
| Return on Assets (ROA) | 2.89% |
| Return on Capital (ROIC) | 3.35% |
| Revenue Per Employee | 228,842 |
| Profits Per Employee | -25,479 |
| Employee Count | 721 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 3.17 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -54.29% in the last 52 weeks. The beta is 2.80, so MariMed's price volatility has been higher than the market average.
| Beta (5Y) | 2.80 |
| 52-Week Price Change | -54.29% |
| 50-Day Moving Average | 0.18 |
| 200-Day Moving Average | 0.23 |
| Relative Strength Index (RSI) | 47.49 |
| Average Volume (20 Days) | 409,061 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.27 |
Income Statement
In the last 12 months, MariMed had revenue of 156.07 million and -17.38 million in losses. Loss per share was -0.05.
| Revenue | 156.07M |
| Gross Profit | 67.54M |
| Operating Income | 9.19M |
| Pretax Income | -9.81M |
| Net Income | -17.38M |
| EBITDA | 19.31M |
| EBIT | 9.19M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 10.19 million in cash and 87.54 million in debt, giving a net cash position of -77.35 million or -0.20 per share.
| Cash & Cash Equivalents | 10.19M |
| Total Debt | 87.54M |
| Net Cash | -77.35M |
| Net Cash Per Share | -0.20 |
| Equity (Book Value) | 87.60M |
| Book Value Per Share | 0.18 |
| Working Capital | 12.40M |
Cash Flow
In the last 12 months, operating cash flow was 17.53 million and capital expenditures -19.68 million, giving a free cash flow of -2.15 million.
| Operating Cash Flow | 17.53M |
| Capital Expenditures | -19.68M |
| Free Cash Flow | -2.15M |
| FCF Per Share | -0.01 |
Margins
Gross margin is 43.27%, with operating and profit margins of 5.89% and -11.13%.
| Gross Margin | 43.27% |
| Operating Margin | 5.89% |
| Pretax Margin | -6.29% |
| Profit Margin | -11.13% |
| EBITDA Margin | 12.37% |
| EBIT Margin | 5.89% |
| FCF Margin | -1.38% |
Dividends & Yields
MariMed does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.54% |
| Shareholder Yield | -2.54% |
| Earnings Yield | -28.44% |
| FCF Yield | -3.47% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MariMed has an Altman Z-Score of 0.86. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.86 |
| Piotroski F-Score | n/a |